Spanish Pharmaceuticals & Biotech Strong Balance Sheet Stocks

Oryzon Genomics

Market Cap: €250.0m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.

Almirall

Market Cap: €2.4b

Operates as a skin health-focused biopharmaceutical company in Spain, Europe, the Middle East, the United States, Asia, and Africa.

Pharma Mar

Market Cap: €1.5b

A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally.

Laboratorio Reig Jofre

Market Cap: €232.8m

A pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics.

Laboratorios Farmaceuticos Rovi

Market Cap: €2.9b

Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.

Faes Farma

Market Cap: €1.3b

Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials worldwide.

Pangaea Oncology

Market Cap: €59.8m

A medical services company, provides a range of services to cancer patients in Spain and the rest of European Union countries.